ORCID Profile
0000-0002-3588-872X
Current Organisations
Queensland University of Technology
,
Virginia Commonwealth University School of Dentistry
Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the Feedback Form.
In Research Link Australia (RLA), "Research Topics" refer to ANZSRC FOR and SEO codes. These topics are either sourced from ANZSRC FOR and SEO codes listed in researchers' related grants or generated by a large language model (LLM) based on their publications.
Theoretical and Computational Chemistry not elsewhere classified | Energy Generation, Conversion and Storage Engineering | Chemical Thermodynamics and Energetics | Theoretical and Computational Chemistry
Expanding Knowledge in the Chemical Sciences | Expanding Knowledge in the Physical Sciences | Energy Storage (excl. Hydrogen) |
Publisher: Elsevier BV
Date: 08-2012
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 2022
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 02-2011
Publisher: Wiley
Date: 29-01-2004
DOI: 10.1002/RNC.887
Publisher: IEEE
Date: 10-2016
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 2023
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 2023
Publisher: IEEE
Date: 2010
Publisher: IEEE
Date: 24-11-2022
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 12-2011
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 2022
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 04-2018
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 2020
Publisher: IEEE
Date: 11-2016
Publisher: Springer Science and Business Media LLC
Date: 21-02-2020
Publisher: IEEE
Date: 12-2013
Publisher: Springer Science and Business Media LLC
Date: 08-07-2019
DOI: 10.1007/S00520-019-04888-W
Abstract: The aim of this systematic review was to update the clinical practice guidelines for the use of anti-inflammatory agents in the prevention and/or treatment of oral mucositis. A systematic review was conducted by the Multinational Association of Supportive Care in Cancer/ International Society of Oral Oncology (MASCC/ISOO) subcommittee on mucositis guideline update. The body of evidence for each intervention, in each cancer treatment setting, was assigned an evidence level. The findings were added to the database used to develop the clinical practice guidelines published in 2014. Based on the evidence level, one of the following three guideline determinations was possible: recommendation, suggestion, and no guidelines. A total of 11 new papers across five interventions were examined. The recommendation for the use of benzydamine mouthwash for the prevention of radiotherapy-induced mucositis remained unchanged. New suggestion for the use of the same for prevention of mucositis associated with chemoradiotherapy was made. No guideline was possible for any other anti-inflammatory agents due to inadequate and/or conflicting evidence. Of the anti-inflammatory agents studied for oral mucositis, the evidence supports the use of benzydamine mouthwash in the specific populations listed above. Additional well-designed research is needed on other (class of agents) interventions and in other cancer treatment settings.
Publisher: Wiley
Date: 28-07-2020
DOI: 10.1002/CNCR.33100
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 11-2007
Publisher: Elsevier BV
Date: 12-2010
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 07-2013
Publisher: Springer Science and Business Media LLC
Date: 08-07-2019
DOI: 10.1007/S00520-019-04892-0
Abstract: The aim of this study was to update the clinical practice guidelines for the use of agents for the prevention and/or treatment of gastrointestinal mucositis (GIM). A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO). The body of evidence for each intervention, in each cancer treatment setting, was assigned an evidence level. Based on the evidence level, one of the following three guideline determinations was possible: Recommendation, Suggestion, and No Guideline Possible. A total of 78 papers across 13 interventions were examined of which 25 were included in the final review. No new guidelines were possible for any agent due to inadequate and/or conflicting evidence. Existing guidelines for probiotics and hyperbaric oxygen were unchanged. Of the agents studied for the prevention and treatment of GIM, the evidence continues to support use of probiotics containing Lactobacillus spp. for prevention of chemoradiotherapy and radiotherapy-induced diarrhea in patients with pelvic malignancy, and hyperbaric oxygen therapy to treat radiation-induced proctitis. Additional well-designed research is encouraged to enable a decision regarding palifermin, glutamine, sodium butyrate, and dietary interventions, for the prevention or treatment of GIM.
Publisher: Springer Science and Business Media LLC
Date: 08-07-2019
DOI: 10.1007/S00520-019-04890-2
Abstract: To systematically review the literature and update the evidence-based clinical practice guidelines for the use of photobiomodulation (PBM), such as laser and other light therapies, for the prevention and/or treatment of oral mucositis (OM). A systematic review was conducted by the Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society for Oral Oncology (MASCC/ISOO) using PubMed and Web of Science. We followed the MASCC methods for systematic review and guidelines development. The rigorously evaluated evidence for each intervention, in each cancer treatment setting, was assigned a level-of-evidence (LoE). Based on the LoE, one of the following guidelines was determined: Recommendation, Suggestion, or No Guideline Possible. Recommendations are made for the prevention of OM and related pain with PBM therapy in cancer patients treated with one of the following modalities: hematopoietic stem cell transplantation, head and neck (H&N) radiotherapy (without chemotherapy), and H&N radiotherapy with chemotherapy. For each of these modalities, we recommend 1-2 clinically effective protocols the clinician should adhere to all parameters of the protocol selected. Due to inadequate evidence, currently, No Guideline Possible for treatment of established OM or for management of chemotherapy-related OM. The reported clinical settings were extremely variable, limiting data integration. The evidence supports the use of specific settings of PBM therapy for the prevention of OM in specific patient populations. Under these circumstances, PBM is recommended for the prevention of OM. The guidelines are subject to continuous update based on new published data.
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 10-2022
Publisher: Institute of Electrical and Electronics Engineers (IEEE)
Date: 06-2022
Publisher: Elsevier BV
Date: 09-2010
Location: United States of America
Location: United States of America
Start Date: 06-2020
End Date: 03-2024
Amount: $419,000.00
Funder: Australian Research Council
View Funded ActivityStart Date: 2015
End Date: 2019
Funder: Japan Society for the Promotion of Science
View Funded ActivityStart Date: 2016
End Date: 2018
Funder: Japan Society for the Promotion of Science
View Funded ActivityStart Date: 2018
End Date: 2013
Funder: German Research Foundation
View Funded ActivityStart Date: 2016
End Date: 2013
Funder: German Research Foundation
View Funded ActivityStart Date: 2012
End Date: 2015
Funder: Japan Society for the Promotion of Science
View Funded ActivityStart Date: 2011
End Date: 2013
Funder: Australian Research Council
View Funded ActivityStart Date: 2009
End Date: 2013
Funder: Australian Research Council
View Funded Activity